Atlas Trials

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

Clinical trial NCT02285218 · UNKNOWN

Trial details

NCT number
NCT02285218
Sponsor
Yonsei University
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-alcoholic Fatty Liver DiseaseType 2 DiabetesMetabolic Syndrome
Start date
2014-04-01
Primary completion
2019-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.